Health Canada
- Status: approved
🇨🇦 tolterodine SR, overactive bladder in Canada
tolterodine SR, overactive bladder (tolterodine SR, overactive bladder) regulatory status in Canada.
Marketing authorisation
tolterodine SR, overactive bladder in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is tolterodine SR, overactive bladder approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for tolterodine SR, overactive bladder in Canada?
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.